acyclovir
Generic: acyclovir
Labeler: bryant ranch prepackDrug Facts
Product Profile
Brand Name
acyclovir
Generic Name
acyclovir
Labeler
bryant ranch prepack
Dosage Form
TABLET
Routes
Active Ingredients
acyclovir 800 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
63629-1678
Product ID
63629-1678_493fe3ca-2fb6-43a4-8bfd-44e53804d6f3
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA075382
Listing Expiration
2026-12-31
Marketing Start
2009-10-22
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
636291678
Hyphenated Format
63629-1678
Supplemental Identifiers
RxCUI
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
acyclovir (source: ndc)
Generic Name
acyclovir (source: ndc)
Application Number
ANDA075382 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 800 mg/1
Packaging
- 500 TABLET in 1 BOTTLE (63629-1678-0)
- 25 TABLET in 1 BOTTLE (63629-1678-1)
- 35 TABLET in 1 BOTTLE (63629-1678-2)
- 30 TABLET in 1 BOTTLE (63629-1678-3)
- 60 TABLET in 1 BOTTLE (63629-1678-4)
- 50 TABLET in 1 BOTTLE (63629-1678-5)
- 10 TABLET in 1 BOTTLE (63629-1678-6)
- 40 TABLET in 1 BOTTLE (63629-1678-7)
- 21 TABLET in 1 BOTTLE (63629-1678-8)
- 90 TABLET in 1 BOTTLE (63629-1678-9)
Packages (10)
63629-1678-0
500 TABLET in 1 BOTTLE (63629-1678-0)
63629-1678-1
25 TABLET in 1 BOTTLE (63629-1678-1)
63629-1678-2
35 TABLET in 1 BOTTLE (63629-1678-2)
63629-1678-3
30 TABLET in 1 BOTTLE (63629-1678-3)
63629-1678-4
60 TABLET in 1 BOTTLE (63629-1678-4)
63629-1678-5
50 TABLET in 1 BOTTLE (63629-1678-5)
63629-1678-6
10 TABLET in 1 BOTTLE (63629-1678-6)
63629-1678-7
40 TABLET in 1 BOTTLE (63629-1678-7)
63629-1678-8
21 TABLET in 1 BOTTLE (63629-1678-8)
63629-1678-9
90 TABLET in 1 BOTTLE (63629-1678-9)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "493fe3ca-2fb6-43a4-8bfd-44e53804d6f3", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197313"], "spl_set_id": ["f3cbd634-77c8-3306-bdbd-a4598b20603e"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (63629-1678-0)", "package_ndc": "63629-1678-0", "marketing_start_date": "20180521"}, {"sample": false, "description": "25 TABLET in 1 BOTTLE (63629-1678-1)", "package_ndc": "63629-1678-1", "marketing_start_date": "20241029"}, {"sample": false, "description": "35 TABLET in 1 BOTTLE (63629-1678-2)", "package_ndc": "63629-1678-2", "marketing_start_date": "20241029"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (63629-1678-3)", "package_ndc": "63629-1678-3", "marketing_start_date": "20241029"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (63629-1678-4)", "package_ndc": "63629-1678-4", "marketing_start_date": "20241029"}, {"sample": false, "description": "50 TABLET in 1 BOTTLE (63629-1678-5)", "package_ndc": "63629-1678-5", "marketing_start_date": "20241029"}, {"sample": false, "description": "10 TABLET in 1 BOTTLE (63629-1678-6)", "package_ndc": "63629-1678-6", "marketing_start_date": "20130328"}, {"sample": false, "description": "40 TABLET in 1 BOTTLE (63629-1678-7)", "package_ndc": "63629-1678-7", "marketing_start_date": "20110609"}, {"sample": false, "description": "21 TABLET in 1 BOTTLE (63629-1678-8)", "package_ndc": "63629-1678-8", "marketing_start_date": "20111117"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (63629-1678-9)", "package_ndc": "63629-1678-9", "marketing_start_date": "20200604"}], "brand_name": "Acyclovir", "product_id": "63629-1678_493fe3ca-2fb6-43a4-8bfd-44e53804d6f3", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "63629-1678", "generic_name": "Acyclovir", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "800 mg/1"}], "application_number": "ANDA075382", "marketing_category": "ANDA", "marketing_start_date": "20091022", "listing_expiration_date": "20261231"}